Perseon plans to sell 4,791,667 units through initial public offering

Shares and five-year warrants sold to finance research and development

By Devika Patel

Knoxville, Tenn., July 27 – Perseon Corp. will sell 4,791,667 units in its initial public sale with a 45-day greenshoe option of 718,750 additional units, according to a Form S-1/A filed Monday with the Securities and Exchange Commission. The company has registered up to $23,963,917.30 of stock, which includes stock underlying the warrants. The sale was announced on April 23.

The units will each consist of one common share and two five-year warrants.

Maxim Group LLC is the bookrunner.

Proceeds will be used for research and development, marketing, selling and general working capital.

The Salt Lake City life sciences company develops, manufactures, markets and services systems to treat cancer and other diseases with heat therapy using focused radiofrequency and microwave energy.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.